Lymperopoulos, A., Sturchler, E., Bathgate-Siryk, A., Dabul, S., Garcia, D., Walklett, K., … Koch, W. J. (2014). Different potencies of angiotensin receptor blockers at suppressing adrenal β-Arrestin1-dependent post-myocardial infarction hyperaldosteronism. J Am Coll Cardiol, 64(25), 2805–2806. https://doi.org/10.1016/j.jacc.2014.09.070

Lymperopoulos, Anastasios, Emmanuel Sturchler, Ashley Bathgate-Siryk, Samalia Dabul, Dilayda Garcia, Karlee Walklett, Giuseppe Rengo, Patricia McDonald, and Walter J. Koch. “Different potencies of angiotensin receptor blockers at suppressing adrenal β-Arrestin1-dependent post-myocardial infarction hyperaldosteronism.” J Am Coll Cardiol 64, no. 25 (December 30, 2014): 2805–6. https://doi.org/10.1016/j.jacc.2014.09.070.

Lymperopoulos A, Sturchler E, Bathgate-Siryk A, Dabul S, Garcia D, Walklett K, et al. Different potencies of angiotensin receptor blockers at suppressing adrenal β-Arrestin1-dependent post-myocardial infarction hyperaldosteronism. J Am Coll Cardiol. 2014 Dec 30;64(25):2805–6.

Lymperopoulos, Anastasios, et al. “Different potencies of angiotensin receptor blockers at suppressing adrenal β-Arrestin1-dependent post-myocardial infarction hyperaldosteronism.” J Am Coll Cardiol, vol. 64, no. 25, Dec. 2014, pp. 2805–06. Pubmed, doi:10.1016/j.jacc.2014.09.070.

Lymperopoulos A, Sturchler E, Bathgate-Siryk A, Dabul S, Garcia D, Walklett K, Rengo G, McDonald P, Koch WJ. Different potencies of angiotensin receptor blockers at suppressing adrenal β-Arrestin1-dependent post-myocardial infarction hyperaldosteronism. J Am Coll Cardiol. 2014 Dec 30;64(25):2805–2806.